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ABSTRACT
Objective: The aim of this study was to determine
whether or not heart rate variability (HRV) analysis
during the first 20 min of head-up tilt testing could
predict whether patients will develop syncope after
nitroglycerine administration.
Design: 64 patients with previous loss of
consciousness underwent head-up tilt testing with the
Italian protocol, which involves the administration of
nitroglycerine after 20 min of tilt. HRV parameters were
analysed from 5 min intervals selected during pretest
supine rest (phase 1), the first 5 min (phase 2) and
the last 5 min (phase 3) of passive 20 min of tilting,
prior to the administration of nitroglycerine. Differences
in power (ms2) of the spectral components between
the various phases of tilting were calculated for each
patient and expressed as Δ.
Results: 20 patients (group 1, 9 women, mean age
43.2±24.5 years) had a syncope during tilt testing after
nitroglycerine, while the other 44 (group 2, 24 women,
mean age 41±20.5 years) did not. In group 1, the HRV
spectral parameters high frequency (HF) and total
power (TP) had a significant decrement from phases 2
to 3 (p=0.012 and 0.027, respectively), while in group
2 the average HF and TP values did not change. The Δ
of spectral parameters between phases 2 and 3 were
able to differentiate between the two groups and to
predict syncope after nitroglycerine administration
(p<0.05).
Conclusions: HRV analysis within the first 20 min of
passive tilting demonstrated that patients with
nitroglycerine-induced syncope are characterised by a
progressive decrement of parasympathetic activity,
which does not occur in patients with a negative
response to nitroglycerine. If confirmed on a wider
population, HRV analysis could replace nitroglycerine
administration and shorten the duration of the tilt test.
OBJECTIVE
Head-up tilt testing (HUT) has a central part
in the diagnosis of vasovagal syncope (VVS).1
Different protocols have been established
over the years, with different strengths and
weaknesses.2–4 The Italian protocol has the
highest sensitivity,5 6 but has at times been
criticised for lower specificity due to the
administration of nitroglycerine.5 7 8
Moreover, in a very recent study carried out
in patients with likely VVS, HUT with nitro-
glycerine had a low-diagnostic value in pre-
dicting long-term outcomes, suggesting that
HUT is of limited value in the management
of patients with suspected neurally mediated
syncope.8
Through the analysis of the heart rate vari-
ability (HRV), a physiological phenomenon
resultant from the dynamic modulation of
HR by the interaction of the sympathetic and
parasympathetic nervous systems activity, it is
possible to study the dynamics of
event-induced changes of cardiac autonomic
modulation.9 10 Thus, HRV analysis is a
powerful, non-invasive tool to explore
dynamic interactions between physiological,
mental, emotional and behavioural pro-
cesses, whose interplay can also be pivotal in
the genesis of syncopal attacks and has been
used to evaluate autonomic adaptation/reac-
tion induced by HUT.11–15
Previous studies have shown contradictory
HRV results during HUT in patients with
VVS and healthy controls. Most authors
agree that HUT induces a decrease in high
frequency (HF) power, calculated in absolute
(ms2) and/or normalised units (nu), vari-
able changes of the low frequency (LF) com-
ponent and an increase in the LF/HF ratio
both in patients with VVS and controls.11 13
KEY MESSAGES
▸ Heart rate variability parameters during the first
20 minutes of head up tilt testing respond differ-
ently in head-up tilt testing (HUT) positive and
negative patients.
▸ Heart rate variability analysis might be useful to
decrease the duration and eliminate the use of
nitroglycerin during head up tilt testing.
▸ Heart rate variability analysis can predict the
outcome of a head up tilt test.
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Other authors, however, have reported inadequate sym-
pathovagal balance in response to orthostatism with a
decrease in LF/HF in patients with positive HUT.16
In two studies, evidence has been provided that the
outcome of HUT can be predicted before the onset of
syncope through simultaneous HRV and blood pressure
measurements, which could reduce the duration of the
tilt testing and avoid induction of unnecessary full synco-
pal events, while maintaining the diagnostic accuracy.7 17
The aim of this study was to evaluate if HRV analysis
performed before the administration of nitroglycerine
could differentiate between negative and positive respon-
ders to HUT, carried out according to the Italian
protocol.
DESIGN
Subjects
Sixty-four patients (31 men, 33 women, mean age 41.7
(SD 21.7) years) who had experienced at least one
episode of spontaneous loss of consciousness during the
previous year, most likely caused by VVS, were enrolled
in the study. All of them underwent medical examina-
tions based on the ESC guidelines. Patients with diabetes
and movement disorders such as Parkinson’s disease
and multiple systemic atrophy, ischaemic cardiomyop-
athy and previous myocardial infarction were excluded,
because the HRV pattern could have been affected by
their underlying disease. Drugs which interact with auto-
nomic modulation were discontinued for at least five
half-lives before the day of HUT.
All patients gave their written consent to participate
before enrolment in the study.
ECG recordings
All recordings were performed with a 12-lead ECG tele-
metric system (Mortara-Rangoni Instruments). Owing to
certain factors, such as circadian rhythm, body position,
activity level prior to recording, medication, verbalisation
and breathing condition, which may influence the HRV,
special precautions were taken to maintain similar condi-
tions in all patients, such as performing the HUT session
at a similar time of the day (usually in mid-late
morning) and having the resting basal recordings after
an adaptation time of at least 20 min.
Head-up tilt test
HUT was performed according to the Italian protocol in
a quiet room at a stable temperature of about 24°C. The
tilt table was electrically driven and equipped with a
footplate support. After a resting period of 20 min in
the supine position under continuous ECG monitoring,
the patient was tilted to 60° for 20 min (the so-called
passive phase). Thereafter, in the absence of spontan-
eous syncope, 300 μg of nitroglycerine spray were admi-
nistered sublingually, and the patient remained tilted for
an additional 20 min (provocation phase), unless
syncope occurred.
The test was considered completed either when the
patient experienced syncope, which required that the
patient be immediately brought in the supine position,
or at the end of the provocation phase in the absence of
symptoms. The haemodynamic response to HUT was
classified according to the VASIS classification.
On the basis of the results of HUT, the patients were
divided into two groups. Group 1 consisted of 20
patients (11 men, 9 women, mean age 43.2 (24.5 SD))
who experienced syncope during HUT, while group 2
involved 44 patients (20 men, 24 women, mean age 41
(20.5 SD)) with a negative response to HUT.
Heart rate variability
Quantitative HRV analysis was performed as follows
according to the guidelines of the European Society of
Cardiology and the North American Society of Pacing
and Electrophysiology.9 The first raw ECG data were
extracted from the telemetric recording with a custom
software routine and edited to manually remove tech-
nical and/or physiological artefacts. The fraction of total
RR intervals labelled as normal-to-normal (NN) intervals
was used as a measure of data reliability, with the
purpose of excluding records with a ratio less than a
90% threshold. Then further editing was performed by
visual analysis of the tachogram and of the correspond-
ing ECG, with manual correction of the possible residual
artefacts. Finally, HRV parameters were calculated in the
time domain (TD), frequency domain (FD) and with
non-linear methods using the Kubios HRV software
(V.2.1).18 19 Arbitrary criteria chosen to optimise the
selection of the time-windows used for calculation were:
(1) the highest possible ‘stationarity’ of the RR signal
(defined as the absence of arrhythmia and of any kind
of artefacts in a visual analysis of the corresponding ECG
recordings) and (2) the best coherence among spectral
output obtained with the Fast Fourier Transform (FFT)
and autoregressive (AR) models. LF and HF in nu and
the LF/HF ratio were calculated from the absolute
values of LF and HF. These values were used as indexes
of sympathovagal interaction to explore autonomic
modulation.20 21
All measurements were performed from three short-
term (5 min) time intervals selected: (1) during the
basal rest phase in the supine position, just before the
start of tilting (phase 1), (2) during the first 5 min of
HUT (phase 2) and (3) during the last 5 min before
the administration of nitroglycerine (phase 3; figure 1).
In order to evaluate if patients who experienced
syncope and those who did not had a different auto-
nomic modulation, the differences in power (in ms2) of
the spectral components between the various phases of
the tlt were calculated for each patient and expressed as
Δ (ie, ΔLF2-LF1, ΔLF3-LF2, etc). Prior to quantitative
analysis, the VLF component was removed using the
‘smoothing prior’ method provided by the Kubios soft-
ware, with the λ value set to 400. Measurement of LF
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and HF power components was made in absolute values
of power (ms2), and in nu.
Statistical analysis
Statistical analysis was performed using Sigmastat 3.5
(Systat) or SPSS V.13.0 (SPSS Inc, Chicago, Illinois,
USA) software. In order to evaluate if there were differ-
ences in the HRV values of each individual group
between the three phases of HUT, the paired t test or
the Wilcoxon Rank Sum test was used, based on the nor-
mality of data distribution.
The Δ of HRV parameters between the different
groups were compared, as appropriate, with the two-
sided unpaired t test or the Mann–Whitney Rank Sum
Test. A two-tailed p value <0.05 was considered statistic-
ally significant. Continuous data are expressed as mean
±1 SD.
Linear Discriminant Analysis (LDA) was used to evalu-
ate if HRV parameters were adequate to provide a separ-
ation between group 1 and group 2 patients. LDA
searches for linear combinations of the input features
that can provide an adequate separation between the
two patient groups. The discriminant functions used by
LDA are built up as a linear combination of the vari-
ables that seek to maximise the differences between the
groups.22 The classification accuracy of the method is
defined as the ability to discriminate between the two
investigated groups.
RESULTS
There were no significant differences between the posi-
tive (group 1) and negative (group 2) responders to
HUT in terms of age and sex. Haemodynamic para-
meters at rest were also similar between the two groups
(table 1). No significant differences in the mean RR
Figure 1 Example of sequential spectral analysis during the tilt test. Boxes on the tachogram (A) indicate the three 5 min
epochs (Ph1: basal rest supine; Ph2: onset of passive tilt and Ph3: end of passive tilt) when HRV parameters are calculated.
Spectral analysis evidence of physiological prevalence of the vagal (HF) component in the supine position (B), and its decrease
(with concomitant increase of the LF component) during the subsequent phases (C and D) of the study (HF, high frequency;
HRV, heart rate variability; LF, low frequency; nu, normalised units). NTG, nitroglycerin; PSD, power spectral density; RR, interval
between subsequent R waves.
Table 1 Demographics and physiological data
Group 1 Group 2 p Value
Group size 20 44
Age 43.2±24.5 41±20.5 NS
Male 11 (55%) 20 (45%) NS
Female 9 (45%) 24 (55%) NS
HR (bpm) 63±8 66±10 NS
SBP (mm Hg) 122±17 117±17 NS
DBP (mm Hg) 75±9 71±9 NS
DBP, diastolic blood pressure; NS, not significant; SBP, systemic
blood pressure.
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intervals in any phase, or in the Δ mean RR, were found
between the two patient groups.
No patient had syncope during the first 20 min of
passive tilt. On average, a positive response to HUT
occurred at about 4 min and 30 s (median 4.5 (2:00–
8:20) min) after the administration of nitroglycerine.
According to the VASIS classification, 5 of the 20 patients
who experienced syncope had mixed-type reflex (type 1),
seven had a pure cardioinhibitory response (type 2) and
eight had a vasodepressor response (type 3).
In phase 1, absolute values of LF, HF and total power
(TP) were slightly higher in group 2 patients than in
group 1 patients, but the difference was not statistically
significant. No difference in the LF/HF ratio was
observed between the two groups.
When comparing phases 1 and 2, a consistent and sig-
nificant decrement of HF power (p<0.001) and incre-
ment of the LF/HF ratio (p=0.002) were found in
group 1 and group 2 patients (figures 2 and 3), with no
significant difference between the two groups. In con-
trast, the behaviour of the LF power was highly variable,
with approximately 60% of patients from both groups
showing an increment and the remainder showing a
decrement of the LF component (p=n.s.; figure 4).
The most relevant difference between the two groups
was found by comparing the phase 2 and phase 3 para-
meters, where the HRV spectral components behaved
differently. In fact, whereas in group 2 patients the
average LF, HF and TP values did not change signifi-
cantly between phases 2 and 3, in group 1 patients the
average HF and TP values showed a significant decrease
(p=0.012 and 0.027, respectively; figures 2 and 5). The
average LF value of group 1 also decreased, but this
change was not significant (p=0.078; figure 4), because
in 30% of the patients the LF component increased.
This variable behaviour of the LF component was appar-
ently unrelated to the mechanism of syncope, since
three of the six patients with an increase in the LF com-
ponent had cardioinhibitory syncope, two had vasode-
pressor syncope and one had a mixed-type response.
Among the patients with a decrease in the LF compo-
nent, four had cardioinhibitory syncope, six had
Figure 2 Box plot of the high
frequency (HF) power, measured
in absolute values (ms2) at the
three phases. The p level of
significance between the different
phases is shown for each group
of patients.
Figure 3 Box plot of the low
frequency/high frequency (LF/HF)
ratio at the three investigated
phases (n.s., not significant).
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vasodepressor syncope and four had a mixed-type
response. The average LF/HF ratio also decreased in
both groups, but the difference was not significant
(p=0.245 and 0.604, respectively; figure 3).
As concerns the Δ of LF, HF and TP between the dif-
ferent phases, those between phases 1 and 2 were not
predictive of syncope during HUT. In contrast, the Δ of
spectral parameters between phases 2 and 3 were able to
differentiate between the two groups and to predict
syncope after nitroglycerine administration (figure 6).
Certain time-domain and non-linear HRV parameters
also showed statistically significant changes in group 1
patients, which were consistent with the previously
described changes in the spectral components. In particu-
lar, RMSSD, pNN50 and SD1 (all indices of vagal modula-
tion, thus correlated to the HF spectral component)
significantly decreased in group 1. In contrast, no signifi-
cant change in group 2 patients was found (table 2 and
figure 7). In addition, SD2, an index of long-term variabil-
ity and also linked to overall variability, decreased between
phases 2 and 3 in group 1 patients, but remained
unchanged in group 2 patients (table 2 and figure 7).
By applying LDA against the whole dataset of HRV
parameters and the Δ between phases 2 and 3, a good
separation was obtained between group 1 and group 2
patients. The highest classification accuracy (80%)
obtained was based on the combination of features ΔHF,
ΔLF, ΔSDNN/RMSSD, ΔLF/HF, ΔTP and HF of phase 2
(ms2), using the following equation:
0:012DHFþ0:006DLF1:115DSDNN=RMSSD
þ0:229DLF=HF0:006DTPþ0:004HF1:374,0
This equation provided 85% sensitivity and 77% specificity
in predicting nitroglycerine-induced syncope during HUT.
DISCUSSION
HUT is a standardised, non-invasive and fast method
suggested by current guidelines for the diagnosis of
reflex VVS.1 However, over the years, different protocols
have been used to improve its sensitivity and
specificity.1–5
Among others, the Italian protocol was developed to
speed up the test and to increase its sensitivity, by intro-
ducing drug-mediated vasodilatation.4 However, some
criticism has risen against this approach in that the
administration of nitroglycerine could enhance the pos-
sibility of false-positive results.5 8
Figure 4 Box plot of the low
frequency (LF) power at the three
investigated phases. Although
non-significant (n.s.), a trend
towards reduction of LF power
between phases 2 and 3 was
observed in group 1 patients.
Figure 5 Box plot of the total
power (TP).
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Given that HRV analysis is well recognised as a
method to evaluate dynamic changes of autonomic
modulation of cardiovascular function9 10 and that the
sympathetic and parasympathetic branches of the
nervous system are greatly affected by the changes that
occur during HUT for syncopal patients, HRV has been
increasingly used in combination with HUT to better
understand the mechanisms involved in the develop-
ment of syncope11–16 and to predict HUT outcome.
Virag et al17 predicted VVS with a 95% sensitivity and
93% specificity in 1150 patients undergoing HUT, using
an algorithm based on the spectral analysis of heart rate
and systolic blood pressure variability.
In the present study, we have found evidence that
patients who will develop syncope after the administra-
tion of nitroglycerine according to the Italian protocol
might be predicted by short-term HRV analysis carried
out at the beginning and at the end of the first 20 min
of HUT, even before the administration of the drug. In
these patients, the power of HF and LF spectral compo-
nents kept decreasing as the passive HUT progressed. In
contrast, HRV parameters of patients who did not
develop syncope with the pharmacological stimulus did
not change significantly along the passive phase of HUT.
Accordingly, the Δ of HF, LF and TP between the first
5 min of HUT and the last 5 min of the 20 min passive
phase of the tilt were significantly different between
group 1 and group 2 patients. These changes were con-
sistent with changes in TD and non-linear HRV para-
meters, further confirming the physiological relevance
of these findings.
With regard to the predictive value of HRV in differen-
tiating between patients who will suffer a syncope at
HUT, HF power has thus far shown the most consistent
behaviour, with a decrease during the interval between
the basal state and the beginning of the tilt observed in
most studies,7 13 23 24 a finding that was consistent with
our results. Duplyakov et al7 and Kochiadakis et al23 con-
sidered the behaviour of HF from the beginning of the
tilt to the period right before the end of HUT, and dis-
covered that HF further decreases in syncopal patients,
while it seems to not vary significantly in HUT-negative
patients. Our results indicate that such a significant
decrease in HF power can be appreciated within the first
20 min of HUT and that this behaviour is predictive of a
positive response to nitroglycerine (ie, patients who will
develop syncope), whereas in patients with a negative
response to nitroglycerine-potentiated HUT the HF
power remains practically unchanged.
Reports on LF behaviour from rest to tilt have been
very contradictory. Some authors found that LF
Figure 6 Different behaviours between group 1 and group 2
patients of the mean and SD of Δ for low frequency (LF), high
frequency (HF) and total power (TP) calculated between the
beginning and the end of the 20 min of passive tilt.
Table 2 Phase-dependent changes of HRV TD and NL parameters during HUT
RMSSD PNN50 SD1 SD2
Group 1 Group 2 Group 1 Group 2 Group 1 Group 2 Group 1 Group 2
Phase 1 39.5±20.6 47.3±29.6 11.7±15.9 22.2±20.4 28.0±14.6 33.5±21.0 44.1±22.1 54.0±29.3
Phase 2 29.1±15.7 28.2±12.5 9.6±11.8 8.2±9.0 20.6±11.1 20.0±8.8 47.7±21.1 48.9±20.4
Phase 3 24.9±12.5 27.9±13.5 6.6±9.4 8.0±9.1 17.7±8.8 19.8±9.5 41.1±19.4 48.8±21.8
p (phase 1 vs 2) 0.003 <0.001 0.004 <0.001 0.003 <0.001 NS NS
p (phase 2 vs 3) 0.004 NS 0.005 NS 0.004 NS 0.032 NS
HRV, heart rate variability; HUT, head-up tilt testing; NL, non linear; NS, not significant; TD, time domain.
Figure 7 Statistically significant differences of the mean and
SD of Δ for some time-domain and non-linear parameters
between group 1 and group 2 patients.
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increases in HUT-positive and HUT-negative
patients;7 12 13 others reported no change in LF power
in HUT-negative patients and a decrement in
HUT-positive patients,23 whereas a third group observed
a decrease in LF power in HUT-positive and
HUT-negative patients.24 In addition, several studies
reported an increase in LF in HUT-positive patients
before the start of the tilt and the occurrence of
syncope.7 23 It has to be considered, however, that the
methods used to calculate the FD metrics differ from
paper to paper and that somehow different results can
be obtained with the FFT and with different orders of
AR models. It is therefore often difficult to compare the
results and conclusions for different studies since there
is often insufficient detail in the papers to determine
how the power spectral density estimates are computed.
In our study, LF behaviour at the start of HUT was vari-
able. On average, a certain decrease in LF power was
observed between phases 2 and 3 in group 1 patients,
which however was not statistically significant (figure 4).
Accordingly, a significant (p=0.027) decrease in TP was
found in group 1 patients in phase 3 of HUT, which was
due to the decrease in LF and HF powers (figure 5).
The LF/HF ratio usually increases on tilt for normal
patients, because sympathetic stimulation manifests as
an increased LF component, which entity is correlated
to the degree of tilt.11 Some authors have described a
higher increment in HUT-positive patients, and sug-
gested that it can be used to predict the outcome of
HUT.7 25 Duplyakov et al7 managed to successfully
predict the outcome of HUT using the LF/HF ratio
during the first 5 min of HUT, but this occurred only in
patients undergoing the Westminster protocol, not the
Italian one, and using FFT for spectral analysis.7 In our
study, no difference was found in the LF/HF ratio
between the two groups using the AR model.26
Although changes in several individual parameters
could differentiate between HUT-positive and
HUT-negative patients in our study, the predictive power
increased significantly when several parameters were
used simultaneously. The changes in all four frequency-
domain parameters, together with the ΔSDNN/RMSSD
and the absolute value of HF during phase 2, gave us
the highest predictive accuracy (80%).
Finally, as concerns the potential use of HRV analysis
to differentiate between the mechanisms of syncope,
Guzman et al27 suggested that a classification based on a
rise or fall of individual HRV parameters was too simplis-
tic to differentiate between patients with different types
of VVS. Within their study population, it was shown that
HF power increased from the basal value to the begin-
ning of the tilt in patients who had vasodepressor
syncope, that the LF/HF ratio was higher in vasodepres-
sor syncope than in cardioinhibitory or mixed-type
syncope, and that patients with cardioinhibitory or
mixed VVS experience an initial rise in the LF/HF ratio
during HUT, whereas vasodepressive VVS patients
experience a drop. We were not able to find any
significant differences between the various types of VVS.
However, this could be due not only to the well-known
high degree of inter-patient variability in the LF/HF
ratio,28 but also to the smaller number of patients with
each type of VVS investigated in our series.
The overall number of investigated patients who
experienced VVS (only 30%) is another limitation of
this study. However, we believe that this does not affect
the outcome of the results, as our goal was to see the dif-
ferences between patients who experience syncope
during HUT according to the Italian protocol and those
who do not, regardless of the origin of their loss of
consciousness.
CONCLUSIONS
In this study, we found that quantitative analysis of time-
related changes of HRV parameters during the first
20 min of passive HUT can foretell the outcome of
nitroglycerine-induced potentiation according to the
Italian protocol without the administration of the drug,
with 80% predictive accuracy. HRV analysis during the
basal period and the first 5 min of the passive tilt was
not sensitive enough to distinguish between patients
who will and those who will not have syncope at HUT
carried out with the Italian protocol. However, evalu-
ation of the dynamic variation of HRV parameters
during the first 20 min of passive HUT evidenced signifi-
cant differences between patients who will develop
syncope after nitroglycerine administration and those
who will not. Further research is warranted to evaluate
whether or not appropriately timed HRV analysis might
improve the differentiation among different mechanisms
of syncope.
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